Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Change in Account Payables (2016 - 2025)

KalVista Pharmaceuticals' Change in Account Payables history spans 10 years, with the latest figure at -$1.4 million for Q2 2025.

  • On a quarterly basis, Change in Account Payables fell 122.83% to -$1.4 million in Q2 2025 year-over-year; TTM through Apr 2025 was $348000.0, a 91.94% decrease, with the full-year FY2025 number at -$5.0 million, down 215.07% from a year prior.
  • Change in Account Payables hit -$1.4 million in Q2 2025 for KalVista Pharmaceuticals, up from -$5.9 million in the prior quarter.
  • Over the last five years, Change in Account Payables for KALV hit a ceiling of $6.1 million in Q2 2024 and a floor of -$5.9 million in Q4 2024.
  • Historically, Change in Account Payables has averaged -$204285.7 across 3 years, with a median of $55000.0 in 2023.
  • The widest YoY moves for Change in Account Payables: up 1290.74% in 2024, down 10754.55% in 2024.
  • Tracing KALV's Change in Account Payables over 3 years: stood at $55000.0 in 2023, then plummeted by 10754.55% to -$5.9 million in 2024, then skyrocketed by 76.25% to -$1.4 million in 2025.
  • Business Quant data shows Change in Account Payables for KALV at -$1.4 million in Q2 2025, -$5.9 million in Q4 2024, and $1.5 million in Q3 2024.